Genome editing using mammalian haploid cells

International Journal of Molecular Sciences

Volumn 16, Issue 10, 2015, Pages 23604-23614

  Horii, Takuro ^a   Hatada, Izuho ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

CRISPR Cas; Embryonic stem cell; Haploid

Indexed keywords

ALCOHOL; ENDONUCLEASE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; STRONTIUM CHLORIDE;

ANDROGENESIS; CELL DIFFERENTIATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DIPLOIDY; DNA END JOINING REPAIR; DNA SEQUENCE; EMBRYONIC STEM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENETIC MANIPULATION; GENETIC PROCEDURES; GENOME; GENOME IMPRINTING; HAPLOIDY; HUMAN; MAMMAL CELL; NONHUMAN; PARTHENOGENESIS; REPRESSOR GENE; REVIEW; ANIMAL; CELL LINE; GENETICS; MAMMAL; METABOLISM; RNA EDITING;

ANIMALS; CELL LINE; EMBRYONIC STEM CELLS; GENOME; HAPLOIDY; HUMANS; MAMMALS; RNA EDITING;

EID: 84943422473     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161023604     Document Type: Review

References (53)

1. Mortensen, R.M.; Zubiaur, M.; Neer, E.J.; Seidman, J.G. Embryonic stem cells lacking a functional inhibitory G-protein subunit (α i2) produced by gene targeting of both alleles. Proc. Natl. Acad. Sci. USA 1991, 88, 7036–7040.
2. Milstone, D.S.; Bradwin, G.; Mortensen, R.M. Simultaneous Cre catalyzed recombination of two alleles to restore neomycin sensitivity and facilitate homozygous mutations. Nucleic Acids Res. 1999, 27, e10, doi:10.1093/nar/27.15.e10.
3. Freed, J.J.; Mezger-Freed, L. Stable haploid cultured cell lines from frog embryos. Proc. Natl. Acad. Sci. USA 1970, 65, 337–344.
4. Graham, C.F. The effect of cell size and DNA content on the cellular regulation of DNA synthesis in haploid and diploid embryos. Exp. Cell Res. 1966, 43, 13–19.
5. Modlinski, J.A. Haploidmouse embryos obtained by microsurgical removal of one pronucleus. J. Embryol. Exp. Morphol. 1975, 33, 897–905.
6. Tarkowski, A.K.; Rossant, J. Haploidmouse blastocysts developed from bisected zygotes. Nature 1976, 259, 663–665.
7. Kaufman, M.H. Chromosome analysis of early postimplantation presumptive haploid parthenogenetic mouse embryos. J. Embryol. Exp. Morphol. 1978, 45, 85–91.
8. Evans, M.J.; Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292, 154–156.
9. Kaufman, M.H.; Robertson, E.J.; Handyside, A.H.; Evans, M.J. Establishment of pluripotential cell-lines from haploid mouse embryos. J. Embryol. Exp. Morph. 1983, 73, 249–261.
10. Yi, M.; Hong, N.; Hong, Y. Generation of medaka fish haploid embryonic stem cells. Science 2009, 326, 430–433.
11. Elling, U.; Taubenschmid, J.; Wirnsberger, G.; O’Malley, R.; Demers, S.P.; Vanhaelen, Q.; Shukalyuk, A.I.; Schmauss, G.; Schramek, D.; Schnuetgen, F. et al. Forward and reverse genetics through derivation of haploid mouse embryonic stem cells. Cell Stem Cell 2011, 9, 563–574.
12. Leeb, M.; Wutz, A. Derivation of haploid embryonic stem cells from mouse embryos. Nature 2011, 479, 131–134.
13. Li, W.; Shuai, L.; Wan, H.; Dong, M.; Wang, M.; Sang, L.; Feng, C.; Luo, G.Z.; Li, T.; Li, X. et al. Androgenetic haploid embryonic stem cells produce live transgenic mice. Nature 2012, 490, 407–411.
14. Yang, H.; Shi, L.; Wang, B.A.; Liang, D.; Zhong, C.; Liu, W.; Nie, Y.; Liu, J.; Zhao, J.; Gao, X. et al. Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells. Cell 2012, 149, 605–617.
15. Wan, H.; He, Z.; Dong, M.; Gu, T.; Luo, G.Z.; Teng, F.; Xia, B.; Li, W.; Feng, C.; Li, X. et al. Parthenogenetic haploid embryonic stem cells produce fertile mice. Cell Res. 2013, 23, 1330–1333.
16. Li, W.; Li, X.; Li, T.; Jiang, M.G.; Wan, H.; Luo, G.Z.; Feng, C.; Cui, X.; Teng, F.; Yuan, Y. et al. Genetic modification and screening in rat using haploid embryonic stem cells. Cell Stem Cell 2013, 14, 404–414.
17. Yang, H.; Liu, Z.; Ma, Y.; Zhong, C.; Yin, Q.; Zhou, C.; Shi, L.; Cai, Y.; Zhao, H.; Wang, H. et al. Generation of haploid embryonic stem cells from Macaca fascicularis monkey parthenotes. Cell Res. 2013, 23, 1187–1200.
18. Kotecki, M.; Reddy, P.S.; Cochran, B.H. Isolation and characterization of a near-haploid human cell line. Exp. Cell Res. 1999, 252, 273–280.
19. Carette, J.E.; Guimaraes, C.P.; Varadarajan, M.; Park, A.S.; Wuethrich, I.; Godarova, A.; Kotecki, M.; Cochran, B.H.; Spooner, E.; Ploegh, H.L. et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 2009, 326, 1231–1235.
20. Carette, J.E.; Raaben, M.; Wong, A.C.; Herbert, A.S.; Obernosterer, G.; Mulherkar, N.; Kuehne, A.I.; Kranzusch, P.J.; Griffin, A.M.; Ruthel, G. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011, 477, 340–343.
21. Rosmarin, D.M.; Carette, J.E.; Olive, A.J.; Starnbach, M.N.; Brummelkamp, T.R.; Ploegh, H.L. Attachment of Chlamydia trachomatis L2 to host cells requires sulfation. Proc. Natl. Acad. Sci. USA 2012, 109, 10059–10064.
22. Reiling, J.H.; Clish, C.B.; Carette, J.E.; Varadarajan, M.; Brummelkamp, T.R.; Sabatini, D.M. A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin. Proc. Natl. Acad. Sci. USA 2011, 108, 11756–11765.
23. Reiling, J.H.; Olive, A.J.; Sanyal, S.; Carette, J.E.; Brummelkamp, T.R.; Ploegh, H.L.; Starnbach, M.N.; Sabatini, D.M. ACREB3-ARF4 signalling pathway mediates the response to Golgi stress and susceptibility to pathogens. Nat. Cell Biol. 2013, 15, 1473–1485.
24. Birsoy, K.; Wang, T.; Possemato, R.; Yilmaz, O.H.; Koch, C.E.; Chen, W.W.; Hutchins, A.W.; Gultekin, Y.; Peterson, T.R.; Carette, J.E. et al. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat. Genet. 2013, 45, 104–108.
25. Leeb, M.; Perry, A.C.; Wutz, A. Establishment and use of mouse haploid ES cells. Curr. Protoc. Mouse Biol. 2015, 5, 155–185.
26. Leeb, M.; Walker, R.; Mansfield, B.; Nichols, J.; Smith, A.; Wutz, A. Germline potential of parthenogenetic haploid mouse embryonic stem cells. Development 2012, 139, 3301–3305.
27. Guo, G.; Yang, J.; Nichols, J.; Hall, J.S.; Eyres, I.; Mansfield, W.; Smith, A. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009, 136, 1063–1069.
28. Takahashi, S.; Lee, J.; Kohda, T.; Matsuzawa, A.; Kawasumi, M.; Kanai-Azuma, M.; Kaneko-Ishino, T.; Ishino, F. Induction of the G2/M transition stabilizes haploid embryonic stem cells. Development 2014, 141, 3842–3847.
29. Cho, S.W.; Kim, S.; Kim, J.M.; Kim, J.S. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 2013, 31, 230–232.
30. Cong, L.; Ran, F.A.; Cox, D.; Lin, S.; Barretto, R.; Habib, N.; Hsu, P.D.; Wu, X.; Jiang, W.; Marraffini, L.A. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339, 819–823.
31. Jinek, M.; East, A.; Cheng, A.; Lin, S.; Ma, E.; Doudna, J. RNA-programmed genome editing in human cells. eLife 2013, 2, e00471, doi:10.7554/eLife.00471.
32. Mali, P.; Yang, L.; Esvelt, K.M.; Aach, J.; Guell, M.; DiCarlo, J.E.; Norville, J.E.; Church, G.M. RNA-guided human genome engineering via Cas9. Science 2013, 339, 823–826.
33. Jinek, M.; Chylinski, K.; Fonfara, I.; Hauer, M.; Doudna, J.A.; Charpentier, E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337, 816–821.
34. Koike-Yusa, H.; Li, Y.; Tan, E.P.; Velasco-Herrera, M.D.C.; Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 2014, 32, 267–273.
35. Shalem, O.; Sanjana, N.E.; Hartenian, E.; Shi, X.; Scott, D.A.; Mikkelsen, T.S.; Heckl, D.; Ebert, B.L.; Root, D.E.; Doench, J.G. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014, 343, 84–87.
36. Wang, T.; Wei, J.J.; Sabatini, D.M.; Lander, E.S. Genetic screens in human cells using the CRISPR-Cas9 system. Science 2014, 343, 80–84.
37. Horii, T.; Tamura, D.; Morita, S.; Kimura, M.; Hatada, I. Generation of an ICF syndrome model by efficient genome editing of human induced pluripotent stem cells using the CRISPR system. Int. J. Mol. Sci. 2013, 14, 19774–19781.
38. An, M.C.; O’Brien, R.N.; Zhang, N.; Patra, B.N.; de La Cruz, M.; Ray A.; Ellerby, L.M. Polyglutamine disease modeling: Epitope based screen for homologous recombination using CRISPR/Cas9 system. PLoS Curr. 2014, 6, doi:10.1371/currents.hd.0242d2e7ad72225efa72f6964589369a.
39. Xie, F.; Ye, L.; Chang, J.C.; Beyer, A.I.; Wang, J.; Muench, M.O.; Kan, Y.W. Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyback. Genome Res. 2014, 24, 1526–1533.
40. Li, H.L.; Fujimoto, N.; Sasakawa, N.; Shirai, S.; Ohkame, T.; Sakuma, T.; Tanaka, M.; Amano, N.; Watanabe, A.; Sakurai, H. et al. Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Rep. 2015, 4, 143–154.
41. Ousterout, D.G.; Kabadi, A.M.; Thakore, P.I.; Majoros, W.H.; Reddy, T.E.; Gersbach, C.A. Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy. Nat. Commun. 2015, 6, 6244, doi:10.1038/ncomms7244.
42. Song, B.; Fan, Y.; He, W.; Zhu, D.; Niu, X.; Wang, D.; Ou, Z.; Luo, M.; Sun, X. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system. Stem Cells Dev. 2015, 24, 1053–1065.
43. Huang, X.; Wang, Y.; Yan, W.; Smith, C.; Ye, Z.; Wang, J.; Gao, Y.; Mendelsohn, L.; Cheng, L. Production of gene-corrected adult β globin protein in human erythrocytes differentiated from patient iPSCs after genome editing of the sickle point mutation. Stem Cells 2015, 33, 1470–1479.
44. Horii, T.; Morita, S.; Kimura, M.; Kobayashi, R.; Tamura, D.; Takahashi, R.U.; Kimura, H.; Suetake, I.; Ohata, H.; Okamoto, K. et al. Genome engineering of mammalian haploid embryonic stem cells using the Cas9/RNA system. PeerJ 2013, 1, e230, doi:10.7717/peerj.230.
45. Wang, H.; Yang, H.; Shivalila, C.S.; Dawlaty, M.M.; Cheng, A.W.; Zhang, F.; Jaenisch, R. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013, 153, 910–918.
46. Canver, M.C.; Bauer, D.E.; Dass, A.; Yien, Y.Y.; Chung, J.; Masuda, T.; Maeda, T.; Paw, B.H.; Orkin, S.H. Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. J. Biol. Chem. 2014, 289, 21312–21324.
47. Kimura, Y.; Oda, M.; Nakatani, T.; Sekita, Y.; Monfort, A.; Wutz, A.; Mochizuki, H.; Nakano, T. CRISPR/Cas9-mediated reporter knock-in in mouse haploid embryonic stem cells. Sci. Rep. 2015, 5, 10710, doi:10.1038/srep10710.
48. Zhong, C.; Yin, Q.; Xie, Z.; Bai, M.; Dong, R.; Tang, W.; Xing, Y.H.; Zhang, H.; Yang, S.; Chen, L.L.; et al. CRISPR-Cas9-Mediated Genetic Screening in Mice with Haploid Embryonic Stem Cells Carrying a Guide RNA Library. Cell Stem Cell 2015, 17, 221–232.
49. Fu, Y.; Foden, J.A.; Khayter, C.; Maeder, M.L.; Reyon, D.; Joung, J.K.; Sander, J.D. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 2013, 31, 822–826.
50. Hsu, P.D.; Scott, D.A.; Weinstein, J.A.; Ran, F.A.; Konermann, S.; Agarwala, V.; Li, Y.; Fine, E.J.; Wu, X.; Shalem, O. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013, 31, 827–832.
51. Pattanayak, V.; Lin, S.; Guilinger, J.P.; Ma, E.; Doudna, J.A.; Liu, D.R. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 2013, 31, 839–843.
52. Yang, H.; Wang, H.; Shivalila, C.S.; Cheng, A.W.; Shi, L.; Jaenisch, R. One-Step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 2013, 154, 1370–1379.
53. Ran, F.A.; Hsu, P.D.; Lin, C.Y.; Gootenberg, J.S.; Konermann, S.; Trevino, A.E.; Scott, D.A.; Inoue, A.; Matoba, S.; Zhang, Y.; Zhang, F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154, 1380–1389.